0001140361-17-011290.txt : 20170309
0001140361-17-011290.hdr.sgml : 20170309
20170309191244
ACCESSION NUMBER: 0001140361-17-011290
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170307
FILED AS OF DATE: 20170309
DATE AS OF CHANGE: 20170309
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HANGER, INC.
CENTRAL INDEX KEY: 0000722723
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
IRS NUMBER: 840904275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
BUSINESS PHONE: 512-777-3800
MAIL ADDRESS:
STREET 1: 10910 DOMAIN DRIVE
STREET 2: SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
FORMER COMPANY:
FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: SEQUEL CORP
DATE OF NAME CHANGE: 19890814
FORMER COMPANY:
FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC
DATE OF NAME CHANGE: 19860304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morton Andrew C.
CENTRAL INDEX KEY: 0001498511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10670
FILM NUMBER: 17679871
MAIL ADDRESS:
STREET 1: C/O HANGER ORTHOPEDIC GROUP, INC.
STREET 2: 10910 DOMAIN DRIVE, SUITE 300
CITY: AUSTIN
STATE: TX
ZIP: 78758
4
1
doc1.xml
FORM 4
X0306
4
2017-03-07
0
0000722723
HANGER, INC.
HGR
0001498511
Morton Andrew C.
10910 DOMAIN DRIVE
SUITE 300
AUSTIN
TX
78758
0
1
0
0
SVP - Human Resources
Common Stock
2017-03-07
4
F
0
347
13.87
D
38033
D
Common Stock
2017-03-08
4
F
0
822
13.77
D
37211
D
Common Stock
2017-03-08
4
A
0
8000
0
A
45211
D
Reflects payment of tax liability by withholding shares of stock incident to vesting of restricted stock previously issued.
Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 8,000 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017.
Includes (i) unvested restricted shares which total 8,000 shares of stock from an initial grant of 8,000 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 7,347 shares of stock from an initial grant of 8,000 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 4,619 shares of stock from an initial grant of 4,958 shares of restricted stock made on November 10, 2015; (v) unvested restricted shares and fully vested shares totaling 3,546 shares of stock from an initial grant of 4,239 shares of restricted stock made on March 6, 2015; [continued in next footnote]
(vi) unvested restricted shares and fully vested shares totaling 1,557 shares of stock from an initial grant of 2,064 shares of restricted stock made on March 7, 2014;(vii) unvested restricted shares and fully vested shares totaling 2,987 shares of stock from an initial grant of 3,958 shares of restricted stock and performance shares made on March 11, 2013; (viii) fully vested shares totaling 2,930 shares of stock from an initial grant of 5,000 shares of restricted stock made on March 7, 2012; (ix) fully vested shares totaling 3,060 shares of stock from an initial grant of 4,900 shares of restricted stock made on March 25, 2011; and (x) fully vested shares totaling 6,165 shares of stock from an initial grant of 12,000 shares of restricted stock made on June 21, 2010. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
/s/ Jessica Lochmann Allen, Attorney-in-Fact for Andrew C. Morton
2017-03-09